Publications

2021 ESC/EACTS Guidelines for the management of valvular heart disease

International audience

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Post-acute COVID-19 syndrome

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure th...

The Lancet Commission on pollution and health

Natural products in drug discovery: advances and opportunities

Cancer treatment and survivorship statistics, 2019

Abstract The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and t...

IntCal09 and Marine09 Radiocarbon Age Calibration Curves, 0–50,000 Years cal BP

The IntCal04 and Marine04 radiocarbon calibration curves have been updated from 12 cal kBP (cal kBP is here defined as thousands of calibrated years before AD 1950), and extende...

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019